Add Company
Join Now

AgoMab Revenue and Competitors

License our Company Data API

Ghent,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AgoMab's estimated annual revenue is currently $8.4M per year.(i)
  • AgoMab's estimated revenue per employee is $124,925

Employee Data

  • AgoMab has 67 Employees.(i)
  • AgoMab grew their employee count by 31% last year.

AgoMab's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Preclinical SafetyReveal Email/Phone
3
General CounselReveal Email/Phone
4
Chief Medical OfficerReveal Email/Phone
5
DMPK managerReveal Email/Phone
6
Manager BioanalysisReveal Email/Phone
7
Project Manager Early DevelopmentReveal Email/Phone
8
Research And Development ChemistReveal Email/Phone
9
Químico de investigación y desarrolloReveal Email/Phone
10
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is AgoMab?

AgomAb is developing molecular therapies for the regeneration of damaged tissues. Our unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

keywords:N/A

N/A

Total Funding

67

Number of Employees

$8.4M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A68143%N/A
#2
$15.3M7142%N/A
#3
$11.3M7328%N/A
#4
$16.9M744%N/A
#5
N/A7822%N/A